Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Summit Therapeutics PLC

+ Add to Watchlist


153.0000 GBp 0.00000.00%

As of 03:52:27 ET on 03/27/2015.

Company Profile for Summit Therapeutics PLC (SUMM)

Summit Therapeutics PLC is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.

Contact Information

Summit Therapeutics PLC

85b Park Drive Milton Park
Abingdon, Oxfordshire
United Kingdom
Phone: 44-123-544-3939
Fax: 44-123-544-3999

Key Executives for Summit Therapeutics PLC (SUMM)

Glyn O EdwardsChief Executive OfficerErik OstrowskiChief Financial Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil